Format

Send to

Choose Destination
See comment in PubMed Commons below
Parkinsons Dis. 2010 Jun 29;2010:342834. doi: 10.4061/2010/342834.

Sleep in genetically confirmed pantothenate kinase-associated neurodegeneration: a video-polysomnographic study.

Author information

  • 1Sleep Disorders Center, Department of Clinical Neurosciences, Vita-Salute San Raffaele University, H San Raffaele-Turro, 20127 Milan, Italy.

Abstract

Pantothenate kinase-associated neurodegeneration (PKAN) is a familial or sporadic disease characterized by extrapyramidal and corticospinal signs with dementia. Patients show iron accumulation in the basal ganglia, with neuronal loss and gliosis. A mutation of pantothenate kinase (PANK2) gene localized on chromosome 20p13 has been described in familiar forms, as well as in sporadic patients. We sought to assess sleep characteristics, including muscle activity during REM sleep, in three patients with PANK2 gene mutation-confirmed diagnosis of PKAN. Sleep architecture was altered in all patients with reduced total time of sleep in two and lack of SWS in one. No significant apnea/hypopnea were detected, and mild PLMS were observed in one patient (PLMS index:10.7/h). In contrast with other neurodegenerative diseases, no REM sleep abnormalities, especially REM sleep behavior disorder, were observed in PKAN patients, and percentage of both REM sleep atonia and phasic EMG activity were within normal ranges. Sleep studies may phenotypically differentiate PKAN from other neurodegenerative disorders.

PMID:
20976082
PMCID:
PMC2957192
DOI:
10.4061/2010/342834
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Hindawi Publishing Corporation Icon for PubMed Central
    Loading ...
    Support Center